Zobrazeno 1 - 10
of 526
pro vyhledávání: '"M, Pauwels"'
Publikováno v:
Tobacco Induced Diseases, Vol 21, Iss July, Pp 1-11 (2023)
Introduction Cigarillos have been reported to provide an alternative to cigarettes with a characterizing flavor, which are banned in the European Union. Additionally, they are cheaper than cigarettes. To better inform policy making, we wanted to gain
Externí odkaz:
https://doaj.org/article/9051ec5a53f54448910e469f1d84c542
Publikováno v:
Toxics, Vol 10, Iss 6, p 283 (2022)
The popularity of heated tobacco products (HTPs) is of concern, as most users are dual users exposed to emissions of both HTPs and conventional cigarettes. Furthermore, HTPs may appeal to young people and non-smokers. This study aims to build intelli
Externí odkaz:
https://doaj.org/article/0909ce0b0ff0482e9a145107a72670f0
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 13 (2020)
Background and aims: Early prediction of the effect of vedolizumab (VDZ) in inflammatory bowel disease (IBD) is of paramount importance to guide clinical decisions. This study assessed whether early fecal calprotectin (FC) can predict endoscopic resp
Externí odkaz:
https://doaj.org/article/924c781f712d443b84c2e2943d1c9b9c
Autor:
J Jansen, L J T Smits, R W M Pauwels, W Kievit, D J de Jong, A C de Vries, F Hoentjen, C J van der Woude, A.A. van Bodegraven, A.G.L. Bodelier, P.J. Boekema, N. de Boer, P.C.J. ter Borg, A.A. den Broeder, I.A.M Gisbertz, F.M Jansen, S.V. Jansen, D.J. de Jong, W. Kievit, R.C.A. van Linschoten, M Löwenberg, M.W.M.D. Lutgens, R.C. Mallant-Hent, A.E. van der Meulen, B. Oldenburg, R.W.M. Pauwels, M Pierik, M.J.L. Romberg-Camps, T.E.H. Römkens, M.G.V.M. Russel, L.J.T. Smits, A.C.I.T.L. Tan, M.L. Verhulst, A.C. de Vries, R.L. West, F.H.J. Wolfhagen, C.J. van der Woude
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Introduction Adalimumab is effective for maintenance of remission in patients with Crohn’s disease (CD) at a dose of 40 mg subcutaneously every 2 weeks. However, adalimumab is associated with (long-term) adverse events and is costly. The aim of thi
Externí odkaz:
https://doaj.org/article/137bae053ba5412d9dec48e602f720d7
Autor:
Renske W. M. Pauwels, Sebastiaan ten Bokkel Huinink, Christien J. van der Woude, M. Doukas, L. Oudijk, Annemarie C. de Vries
Background: Response evaluation after induction therapy with ustekinumab (UST) in Crohn’s disease (CD) is important for decisions on maintenance therapy. We aimed to assess the potential of fecal calprotectin (FC) levels to predict endoscopic respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b5afd7ab9ef096661c785b149ff8150
Autor:
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, Lisa J T Smits, Femke Atsma, Wietske Kievit, Dirk J de Jong, Annemarie C de Vries, Paul J Boekema, Rachel L West, Alexander G L Bodelier, Ingrid A M Gisbertz, Frank H J Wolfhagen, Tessa E H Römkens, Maurice W M D Lutgens, Adriaan A van Bodegraven, Bas Oldenburg, Marieke J Pierik, Maurice G V M Russel, Nanne K de Boer, Rosalie C Mallant-Hent, Pieter C J ter Borg, Andrea E van der Meulen-de Jong, Jeroen M Jansen, Sita V Jansen, Adrianus C I T L Tan, C Janneke van der Woude, Frank Hoentjen, Desirée van Noord, Jildou Hoekstra, Johannes T. Kamphuis, Moniek H.P. Gorter, Aura A.J. van Esch
Publikováno v:
Lancet Gastroenterology & Hepatology, 8, 4, pp. 343-355
Lancet Gastroenterology & Hepatology, 8, 343-355
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd
LADI study group and the Dutch Initiative on Crohn and Colitis 2023, ' Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) : a pragmatic, open-label, non-inferiority, randomised controlled trial ', The Lancet Gastroenterology and Hepatology, vol. 8, no. 4, pp. 343-355 . https://doi.org/10.1016/S2468-1253(22)00434-4
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd.
Lancet Gastroenterology & Hepatology, 8, 343-355
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd
LADI study group and the Dutch Initiative on Crohn and Colitis 2023, ' Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) : a pragmatic, open-label, non-inferiority, randomised controlled trial ', The Lancet Gastroenterology and Hepatology, vol. 8, no. 4, pp. 343-355 . https://doi.org/10.1016/S2468-1253(22)00434-4
The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd.
Item does not contain fulltext BACKGROUND: Despite its effectiveness in treating Crohn's disease, adalimumab is associated with an increased risk of infections and high health-care costs. We aimed to assess clinical outcomes of increased adalimumab d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4a13f67ca392c8811058105e50cf3a
https://repository.ubn.ru.nl/handle/2066/293716
https://repository.ubn.ru.nl/handle/2066/293716
Autor:
Elisa Proietti, Renske W M Pauwels, Christien J van der Woude, Michael Doukas, Lindsey Oudijk, Maikel P Peppelenbosch, Ursula Grohmann, Marie-Rose B S Crombag, Annemarie C de Vries, Gwenny M Fuhler
Publikováno v:
Inflammatory Bowel Diseases. Oxford University Press
Background Ustekinumab (UST), which targets p40/interleukin (IL)-23 and IL-12, is an effective treatment for Crohn’s disease (CD). Therapeutic drug monitoring may optimize UST posology. The aim of this study was to investigate UST and IL-23 serum a
Publikováno v:
Toxics; Volume 10; Issue 6; Pages: 283
The popularity of heated tobacco products (HTPs) is of concern, as most users are dual users exposed to emissions of both HTPs and conventional cigarettes. Furthermore, HTPs may appeal to young people and non-smokers. This study aims to build intelli
In this article the author name Luigi Calligaris was incorrectly written as A. Calligaris. The original article has been corrected. © CERN for the benefit of the CMS collaboration 2022.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d4602f856d8b7a2ef1770f71d6012cb0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219595
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219595
Autor:
Reinskje Talhout, Geoffrey Ferris Wayne, Walther N M Klerx, Jeroen L. A. Pennings, Charlotte G G M Pauwels
ObjectivesSensory experience is an important determinant of smoking initiation, brand choice and harm perception, but little is known about how cigarette design shapes sensory experience. This study reports which variations in tobacco blend and desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e71e721c9955b41721c8e616c8c7d4af
http://hdl.handle.net/10029/625430
http://hdl.handle.net/10029/625430